|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Loreal USA |
| Information provided by: | Loreal USA |
| ClinicalTrials.gov Identifier: | NCT00368563 |
Purpose
To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using capacitance and transepidermal water loss methodology
| Condition | Intervention | Phase |
|
Dry Skin |
Drug: Helioblock SX |
Phase II Phase III |
| MedlinePlus related topics: | Drinking Water |
| Study Type: | Interventional |
| Study Design: | Randomized, Single Blind, Uncontrolled, Single Group Assignment |
Eligibility
| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Jennifer Mann, B.A. | 480-949-7766 ext 240 |
| United States, Arizona | |||||
| Hill Top Research | Recruiting | ||||
| Scottsdale, Arizona, United States, 85251 | |||||
| Contact: Jennifer Mann, B.A. 480-949-7766 ext 240 | |||||
| Loreal USA |
| Principal Investigator: | Linda Oddo, B.S. | Hill Top Research |
More Information
| Study ID Numbers: | PEN.1010.02 |
| First Received: | August 23, 2006 |
| Last Updated: | August 23, 2006 |
| ClinicalTrials.gov Identifier: | NCT00368563 |
| Health Authority: | United States: Food and Drug Administration |